Patents by Inventor Jonathan C. Lansing

Jonathan C. Lansing has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
    Publication number: 20250011432
    Abstract: The present invention relates to compositions and methods of engineered IgG Fc constructs, wherein said Fc constructs include one or more Fc domains.
    Type: Application
    Filed: June 25, 2024
    Publication date: January 9, 2025
    Inventors: Carlos J. Bosques, James S. Huston, Jonathan C. Lansing, Leona E. Ling, James Meador, III, Daniel Ortiz, Laura Rutitzky
  • Compositions and methods related to engineered Fc constructs
    Patent number: 12071482
    Abstract: The present invention relates to compositions and methods of engineered IgG Fc constructs, wherein said Fc constructs include one or more Fc domains.
    Type: Grant
    Filed: August 20, 2021
    Date of Patent: August 27, 2024
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Carlos J. Bosques, James S. Huston, Jonathan C. Lansing, Leona E. Ling, James Meador, III, Daniel Ortiz, Laura Rutitzky
  • Sialylated Glycoproteins
    Publication number: 20240279703
    Abstract: Glycoproteins having particular sialylation patterns, and methods of making and using such glycoproteins, are described.
    Type: Application
    Filed: July 5, 2023
    Publication date: August 22, 2024
    Inventors: Naveen Bhatnagar, Robin Meccariello, Jonathan C. Lansing, Daniel Ortiz, Hetal Sarvaiya, Nathaniel J. Washburn
  • ENGINEERED Fc CONSTRUCTS
    Publication number: 20240209040
    Abstract: The present disclosure relates to engineered IgG Fc constructs and uses thereof.
    Type: Application
    Filed: November 27, 2023
    Publication date: June 27, 2024
    Inventors: Carlos J. Bosques, Jonathan C. Lansing, Daniel Ortiz
  • Sialylated Glycoproteins
    Publication number: 20240167069
    Abstract: Glycoproteins having particular sialylation patterns, and methods of making and using such glycoproteins, are described.
    Type: Application
    Filed: July 6, 2023
    Publication date: May 23, 2024
    Inventors: Naveen Bhatnagar, Robin Meccariello, Jonathan C. Lansing, Daniel Ortiz, Hetal Sarvaiya, Nathaniel J. Washburn
  • Sialylated Glycoproteins
    Publication number: 20240141401
    Abstract: Glycoproteins having particular sialylation patterns, and methods of making and using such glycoproteins, are described.
    Type: Application
    Filed: June 30, 2023
    Publication date: May 2, 2024
    Inventors: Naveen Bhatnagar, Robin Meccariello, Jonathan C. Lansing, Daniel Ortiz, Hetal Sarvaiya, Nathaniel J. Washburn
  • COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
    Publication number: 20240067757
    Abstract: The present disclosure relates to compositions and methods of engineered IgG Fc constructs, wherein the Fc constructs include one or more Fc domains.
    Type: Application
    Filed: April 10, 2023
    Publication date: February 29, 2024
    Inventors: Jonathan C. Lansing, Carlos J. Bosques, Daniel Ortiz
  • Engineered Fc constructs
    Patent number: 11827682
    Abstract: The present disclosure relates to engineered IgG Fc constructs and uses thereof.
    Type: Grant
    Filed: November 16, 2021
    Date of Patent: November 28, 2023
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Carlos J. Bosques, Jonathan C. Lansing, Daniel Ortiz
  • Compositions and methods related to engineered Fc constructs
    Patent number: 11623964
    Abstract: The present disclosure relates to compositions and methods of engineered IgG Fc constructs, wherein the Fc constructs include one or more Fc domains.
    Type: Grant
    Filed: May 23, 2017
    Date of Patent: April 11, 2023
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Jonathan C. Lansing, Carlos J. Bosques, Daniel Ortiz
  • COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN CONSTRUCTS
    Publication number: 20220267460
    Abstract: The present disclosure relates to compositions and methods of engineered Fc-antigen binding domain constructs, where the Fc-antigen binding domain constructs include at least two Fc domains and at least one antigen binding domain.
    Type: Application
    Filed: July 11, 2019
    Publication date: August 25, 2022
    Inventors: Jonathan C. Lansing, Daniel Ortiz
  • ENGINEERED Fc CONSTRUCTS
    Publication number: 20220267388
    Abstract: The present disclosure relates to engineered IgG Fc constructs and uses thereof.
    Type: Application
    Filed: November 16, 2021
    Publication date: August 25, 2022
    Inventors: Carlos J. Bosques, Jonathan C. Lansing, Daniel Ortiz
  • METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
    Publication number: 20220153833
    Abstract: The present invention relates to methods of using biologically active Fc domain-containing therapeutic constructs (Fc constructs) to induce immune cell activation of the immune response in a subject, and for example, to treat diseases such as cancers and infections in a subject. Such Fc constructs may include 5 or more Fc domains.
    Type: Application
    Filed: March 2, 2017
    Publication date: May 19, 2022
    Inventors: Carlos J. Bosques, James S. Huston, Jonathan C. Lansing, Leona E. Ling, James Meador, III, Daniel Ortiz, Laura Rutitzky, Birgit C. Schultes
  • COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN CONSTRUCTS TARGETED TO CTLA-4
    Publication number: 20220064298
    Abstract: Fc-antigen binding constructs having a CTLA-4 binding domain and two or more Fc domains are described as are methods for using such constructs. Also described are polypeptides making up such constructs.
    Type: Application
    Filed: July 11, 2019
    Publication date: March 3, 2022
    Inventors: Anthony Manning, Jonathan C. Lansing, Daniel Ortiz, Laura Rutitzky
  • COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
    Publication number: 20220049019
    Abstract: The present disclosure relates to engineered IgG Fc constructs and uses thereof.
    Type: Application
    Filed: October 1, 2021
    Publication date: February 17, 2022
    Inventors: Carlos J. Bosques, Jonathan C. Lansing, Daniel Ortiz, Laura Rutitzky, Nathaniel J. Washburn
  • COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS
    Publication number: 20220033499
    Abstract: The present invention relates to compositions and methods of engineered IgG Fc constructs, wherein said Fc constructs include one or more Fc domains.
    Type: Application
    Filed: August 20, 2021
    Publication date: February 3, 2022
    Inventors: Carlos J. Bosques, James S. Huston, Jonathan C. Lansing, Leona E. Ling, James Meador, III, Daniel Ortiz, Laura Rutitzky
  • Engineered Fc constructs
    Patent number: 11220531
    Abstract: The present disclosure relates to engineered IgG Fc constructs and uses thereof.
    Type: Grant
    Filed: January 5, 2018
    Date of Patent: January 11, 2022
    Assignee: Janssen Biotech, Inc.
    Inventors: Carlos J. Bosques, Jonathan C. Lansing, Daniel Ortiz
  • Compositions and methods related to engineered Fc constructs
    Patent number: 11155640
    Abstract: The present invention relates to engineered IgG Fc constructs and uses thereof.
    Type: Grant
    Filed: May 23, 2017
    Date of Patent: October 26, 2021
    Assignee: Janssen Biotech, Inc.
    Inventors: Carlos J. Bosques, Jonathan C. Lansing, Daniel Ortiz, Laura Rutitzky, Nathaniel J. Washburn
  • COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN CONSTRUCTS
    Publication number: 20210317227
    Abstract: The present disclosure relates to compositions and methods of engineered Fc-antigen binding domain constructs, where the Fc-antigen binding domain constructs include at least two Fc domains and at least one antigen binding domain.
    Type: Application
    Filed: July 11, 2019
    Publication date: October 14, 2021
    Inventors: Jonathan C. Lansing, Daniel Ortiz, Carlos J. Bosques
  • Compositions and methods related to engineered Fc constructs
    Patent number: 11124573
    Abstract: The present invention relates to compositions and methods of engineered IgG Fc constructs, wherein said Fc constructs include one or more Fc domains.
    Type: Grant
    Filed: March 25, 2019
    Date of Patent: September 21, 2021
    Assignee: Janssen Biotech, Inc.
    Inventors: Carlos J. Bosques, James S. Huston, Jonathan C. Lansing, Leona E. Ling, James Meador, III, Daniel Ortiz, Laura Rutitzky
  • COMPOSITIONS AND METHODS RELATED TO ENGINEERED FC-ANTIGEN BINDING DOMAIN CONSTRUCTS
    Publication number: 20210284717
    Abstract: The present disclosure relates to compositions and methods of engineered Fc-antigen binding domain constructs, where the Fc-antigen binding domain constructs include at least two Fc domains and at least one antigen binding domain.
    Type: Application
    Filed: July 11, 2019
    Publication date: September 16, 2021
    Inventors: Jonathan C. Lansing, Daniel Ortiz